{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:10:08Z","timestamp":1759457408444,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1053\/j.ajkd.2004.03.030","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T11:49:20Z","timestamp":1134474560000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis"],"prefix":"10.1053","volume":"44","author":[{"given":"Kouichi","family":"Hirayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joichi","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigyou","family":"Yoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohji","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2004.03.030_BIB1","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne","year":"1995","journal-title":"QJM"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.V7133","article-title":"Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Nackman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangitis with renal involvement","volume":"9","author":"Westman","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB4","first-page":"125","article-title":"Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients","volume":"39","author":"Geffriaud-Ricouard","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9343(99)00064-9","article-title":"Serial managements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis","volume":"106","author":"Kyndt","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB6","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1755.2003.00821.x","article-title":"Serial ANCA titers","volume":"63","author":"Han","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q","article-title":"Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement","volume":"41","author":"Haubitz","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB9","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","article-title":"The value of pulse cyclophosphamide in ANCA-associated vasculitis","volume":"16","author":"de Groot","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1399-0012.1990.tb00009.x","article-title":"Low-dose cyclosporine, mizoribine and prednisolone in renal transplantation","volume":"4","author":"Kokado","year":"1990","journal-title":"Clin Transplant"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB13","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vaculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7164\/antibiotics.27.775","article-title":"Studies on bredinin. I. Isolation, characterization and biological properties","volume":"27","author":"Mizuno","year":"1974","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1172\/JCI115101","article-title":"Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine","volume":"87","author":"Turka","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0026-895X(25)09004-2","article-title":"Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptoprine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism","volume":"41","author":"Dayton","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0090-1229(84)90290-3","article-title":"Effect of mizoribine on lupus nephropathy of New Zealand black\/white F1 hybrid mice","volume":"33","author":"Kamata","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/08916939608994722","article-title":"Effect of mizoribine on pulmonary lesions in MRL\/lpr\/lpr mice","volume":"25","author":"Soga","year":"1996","journal-title":"Autoimmunity"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000168992","article-title":"Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside","volume":"16","author":"Shibasaki","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000044994","article-title":"Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice","volume":"79","author":"Shimizu","year":"1998","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB21","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/S0041-1345(99)00599-0","article-title":"Long-term results in mizoribine-treated renal transplant recipients","volume":"31","author":"Tanabe","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB22","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/S0041-1345(01)02383-1","article-title":"The efficacy and safety of mizoribine in living donor kidney transplantation","volume":"33","author":"Cho","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","article-title":"A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephritic syndrome","volume":"58","author":"Yoshioka","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB24","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangitis","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB25","first-page":"61","article-title":"Dose comparison of bredinin on rheumatoid arthritis","volume":"18","author":"Kondo","year":"1998","journal-title":"Jpn J Inflamm"},{"key":"10.1053\/j.ajkd.2004.03.030_BIB26","first-page":"829","article-title":"Absorption, distribution, metabolism and excretion of bredinin in rats","volume":"15","author":"Murase","year":"1978","journal-title":"Appl Pharmacol (Tokyo)"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860400513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860400513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:28:45Z","timestamp":1759454925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263860400513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S027263860400513X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2004.03.030","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2004.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}